News & Industry Updates

Press Releases May 19, 2025

ReAlta Life Sciences Announces New Inflammatory Biomarker Data from Acute Exacerbations of...

NORFOLK, Va.–ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the...

Read More

Press Releases Apr 25, 2025

ReAlta Life Sciences Announces New Clinical Data for RLS-0071 (pegtarazimod) from Hypoxic...

Data confirm elevated inflammatory biomarkers in newborns with Hypoxic Ischemic Encephalopathy (HIE) and demonstrate a predictable pharmacokinetic profile for RLS-0071...

Read More

Press Releases Apr 08, 2025

ReAlta Life Sciences to Present New Clinical Data from Hypoxic Ischemic Encephalopathy...

NORFOLK, Va.–ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the...

Read More

Press Releases Apr 01, 2025

ReAlta Life Sciences Announces Appointment of Distinguished Immunologist, Laurie Glimcher, M.D., to...

NORFOLK, Va.–ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated to saving lives by rebalancing the...

Read More

Press Releases Feb 25, 2025

ReAlta Life Sciences Announces Appointment of Biotechnology Leader Andrew Miller, Ph.D., to...

NORFOLK, Va. – February 25, 2025 – ReAlta Life Sciences, Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company dedicated...

Read More